The PON1 polymorphism did not modulate the risk of CAD in response to exposure to other traditional risk factors such as the following: male gender, hypertension, diabetes mellitus, overweight/obesity, and plasma lipid abnormalities (Table 4). Here, PON1 is linked to obesity disorder.